OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
When cardiovascular medicines should be discontinued
Konstantin A. Krychtiuk, Bernard J. Gersh, Jeffrey B. Washam, et al.
European Heart Journal (2024) Vol. 45, Iss. 23, pp. 2039-2051
Closed Access | Times Cited: 10
Konstantin A. Krychtiuk, Bernard J. Gersh, Jeffrey B. Washam, et al.
European Heart Journal (2024) Vol. 45, Iss. 23, pp. 2039-2051
Closed Access | Times Cited: 10
Showing 10 citing articles:
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC
Davide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, et al.
European Journal of Heart Failure (2025)
Open Access | Times Cited: 2
Davide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, et al.
European Journal of Heart Failure (2025)
Open Access | Times Cited: 2
Older Adults’ Attitudes Toward Deprescribing in 14 Countries
Renata Vidonscky Lüthold, Katharina Tabea Jungo, Kristie Rebecca Weir, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457498-e2457498
Open Access | Times Cited: 1
Renata Vidonscky Lüthold, Katharina Tabea Jungo, Kristie Rebecca Weir, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457498-e2457498
Open Access | Times Cited: 1
Endothelial dysfunction in chronic obstructive pulmonary disease: an update on mechanisms, assessment tools and treatment strategies
Giuseppina Marcuccio, Claudio Candia, Mauro Maniscalco, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 1
Giuseppina Marcuccio, Claudio Candia, Mauro Maniscalco, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 1
When “old” lipid lowering therapies not should be discontinued
Francesco Sbrana, Beatrice Dal Pino
Clínica e Investigación en Arteriosclerosis (English Edition) (2025) Vol. 37, Iss. 1, pp. 100732-100732
Closed Access
Francesco Sbrana, Beatrice Dal Pino
Clínica e Investigación en Arteriosclerosis (English Edition) (2025) Vol. 37, Iss. 1, pp. 100732-100732
Closed Access
Practices of low value or unnecessary practices in vascular prevention
C. Brotons, Irene Moral, J M García Abajo, et al.
Hipertensión y Riesgo Vascular (2025)
Closed Access
C. Brotons, Irene Moral, J M García Abajo, et al.
Hipertensión y Riesgo Vascular (2025)
Closed Access
Advancement of the Implementation of Evidence-based Therapies for Cardiovascular-Kidney-Metabolic Conditions: A Multi-Stakeholder Perspective
Nkiru Osude, Harriette Van Spall, Hayden B. Bosworth, et al.
American Heart Journal (2025)
Closed Access
Nkiru Osude, Harriette Van Spall, Hayden B. Bosworth, et al.
American Heart Journal (2025)
Closed Access
The evolving management of adult congenital heart disease: focus on biomarkers and cardiac magnetic resonance
Filippo Crea
European Heart Journal (2024) Vol. 45, Iss. 23, pp. 2025-2028
Open Access | Times Cited: 1
Filippo Crea
European Heart Journal (2024) Vol. 45, Iss. 23, pp. 2025-2028
Open Access | Times Cited: 1
When “old” lipid lowering therapies not should be discontinued
Francesco Sbrana, Beatrice Dal Pino
Clínica e Investigación en Arteriosclerosis (2024)
Closed Access
Francesco Sbrana, Beatrice Dal Pino
Clínica e Investigación en Arteriosclerosis (2024)
Closed Access
Optimizing long-term prevention of cardiovascular disease with reinforcement learning
Yekai Zhou, Ruibang Luo, Joseph E. Blais, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Yekai Zhou, Ruibang Luo, Joseph E. Blais, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
